RENAISSANCE TECHNOLOGIES LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1037389
NEW YORK, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$158,957,573
-$29,342,986 QoQ
Shares Held
320,008
-24.1% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#82
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. VRTX ranks #4 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $158,957,573 | 320,008 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $188,300,559 | 421,688 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $228,968,561 | 505,048 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $288,203,176 | 735,888 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $447,376,137 | 1,004,888 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $568,001,052 | 1,171,571 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $562,656,064 | 1,397,209 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $758,774,764 | 1,631,493 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $734,197,383 | 1,566,388 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $660,659,788 | 1,580,488 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $647,641,930 | 1,591,688 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $578,669,961 | 1,664,088 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $447,686,177 | 1,272,161 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $440,384,366 | 1,397,735 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $648,817,042 | 2,246,752 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $619,292,762 | 2,138,885 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $496,279,530 | 1,761,168 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $445,571,826 | 1,707,368 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $357,260,212 | 1,626,868 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $343,096,645 | 1,891,486 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $459,168,772 | 2,277,284 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $515,797,028 | 2,400,284 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $845,135,296 | 3,575,930 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,416,910,335 | 5,206,932 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,678,378,492 | 5,781,332 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,632,261,331 | 6,859,682 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||